Furthermore, compound 1 decreased the protein and mRNA expression levels of Rubicon (Figure 5B,D), an inhibitor of autophagy that has been reported to be associated with NAFLD because of its increased concentration in the liver of high-fat diet-loaded mice, resulting in inhibition of lipid droplet degradation [61]. The gene discussed is RUBCN; the disease is metabolic dysfunction-associated steatotic liver disease.